# OnCo record biond-biologics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/biond-biologics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "biond-biologics" ;
  schema:name "Biond Biologics"@en ;
  schema:alternateName "Biond Biologics Ltd."@en ;
  schema:description "Biond Biologics is an Israeli company making antibodies that release new immune brakes so the immune system can attack tumours. Its lead antibody, BND-22, is in a phase 2 study with standard immunotherapy, and BND-35 has finished an early safety study."@en ;
  schema:url <https://onco.cc/companies/biond-biologics/>, <https://www.biondbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.biondbio.com/>, <https://clinicaltrials.gov/study/NCT06274437>, <https://www.biondbio.com/press/> ;
  schema:addressCountry "IL" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/lilrb1/>, <https://onco.cc/targets/cd28/> .